Peptide COA Glossary: How to Read Every Term on a Certificate of Analysis (+ Legit Checklist)

This page is a reference: a term-by-term glossary of everything printed on a research-peptide Certificate of Analysis, followed by a short yes/no checklist for deciding whether the specific COA in front of you is legitimate. Every entry gives the plain definition, what the term actually proves, and the red flag attached to it, because most COA deception works by using real analytical vocabulary inside a document that has no lab record behind it. That is the deciding point worth internalizing before you read a single number below: a purity figure, a molecular weight, a net content value in milligrams - none of them mean anything on their own. They mean something only when the report carrying them was issued by a named third-party laboratory and can be re-opened by you, by accession number, on that laboratory’s own domain. The vocabulary makes you literate. The lookup makes you safe. You need both.

Published 2026 - For research use only (RUO). Nothing here is medical advice, a dosing protocol, or a human-use recommendation. All arithmetic below is standard laboratory characterization math for handling a research sample.

In a hurry? Jump to how Pepora scores on the checklist →

This glossary is deliberately narrow. It does not re-teach the walkthrough in how to read a peptide COA, and it does not repeat the step-by-step lookup procedure in how to verify a peptide COA by accession code. It is the reference layer underneath both: the definitions you look up mid-report, and the pass/fail test you run in ninety seconds.

---

Part 1: the COA glossary at a glance

Each term links to its full entry below.

Term	One-line definition	The associated red flag
HPLC purity	Main peak area ÷ total detected peak area, as a percentage	A percentage with no chromatogram is an assertion, not evidence
Mass-spec identity	Observed mass compared against the theoretical mass of the sequence	Purity reported with identity never confirmed
Chromatogram	The plotted detector trace the purity number is calculated from	Missing, illegible, or contradicting the stated percentage
Retention time	When the analyte elutes from the column, in minutes	No method conditions makes the retention time uncheckable
Net peptide content (NPC)	Actual mass of peptide in the vial, excluding salts and water	Not stated at all, so true content is unknown
TFA vs acetate salt	Which counterion is bound; changes peptide mass per mg of powder	Salt form never declared
Lot / batch number	The production unit the tested sample was drawn from	Blank on the COA, or different from the number on your vial
Accession / report number	The lab’s identifier that lets you re-open the record	Absent, or present but resolving to nothing
Test and receipt dates	When the lab received and analyzed the sample	Years old, or reused across visibly newer stock
Accreditation	Formal recognition of a lab’s competence, e.g. ISO/IEC 17025	A logo asserted on the vendor’s page but absent from any directory
LOD / LOQ and reporting threshold	The smallest impurity the method can see and quantify	“No impurities detected” with no stated detection limit
Specific tests	Water content, residual solvents, endotoxin, and similar	A “flawless everything” panel with no numbers behind it

---

Part 1 in full: the glossary

HPLC purity (area %)

Reversed-phase high-performance liquid chromatography separates a peptide sample by hydrophobicity as it passes through a column, and a detector records a signal as each component elutes. Purity is reported as the area of the main peak divided by the total area of all detected peaks, expressed as a percentage [3]. Peptide reference-standard practice describes exactly this quantity - impurities summed as a share of “% total detected area” [1]. Critically, this is an area percent, not a mass percent: it tells you what fraction of the detected material is the target compound, and nothing more.

The detection wavelength matters more than most buyers realize. Peptides are typically detected in the 214-220 nm range because that is where the amide (peptide) bond absorbs; the peptide bond has a measured molar extinction coefficient of 923 M⁻¹cm⁻¹ at 214 nm, determined in the presence of acetonitrile and formic acid [7]. Anything in the vial that does not absorb in that window - water, inorganic salts, bound counterions, some small organics - produces no peak and is therefore not counted in the purity calculation at all. This is the single most misread fact on any COA.

Red flag: a purity percentage printed without the chromatogram it was calculated from. The number is the output; the trace is the evidence. A report giving you only the output is asking you to trust arithmetic you cannot inspect.

Mass-spectrometry identity

Mass spectrometry answers a completely different question from HPLC: not how much of the material is the target, but whether the molecule is the target at all. The instrument measures mass-to-charge ratio, and the observed mass is compared against the theoretical mass calculated from the amino-acid sequence [2]. A match within a small tolerance is identity confirmation. A mismatch means you have a different compound, at any purity whatsoever.

Two mass conventions appear on reports and they are not interchangeable. Monoisotopic mass uses the lightest isotope of each element and is what high-resolution instruments typically report; average mass weights each element by natural isotopic abundance and is the figure usually quoted on product pages. For a typical peptide the two differ by roughly 0.06% of the mass - on the order of 0.6 Da at 1,000 Da and about 3 Da at 5,000 Da - which is small, but more than enough to look like a discrepancy if you compare the wrong pair. (Angiotensin II, C₅₀H₇₁N₁₃O₁₂, is a clean illustration: monoisotopic 1045.53 Da against average 1046.2 Da.) Standardized terminology for these concepts is set out in the IUPAC mass-spectrometry recommendations [8].

Red flag: a COA with a purity section and no identity section. HPLC alone can show a beautifully clean single peak that is 99% of entirely the wrong molecule. Identity and purity are orthogonal, and a report needs both.

Chromatogram

The chromatogram is the plotted trace itself: detector response on the y-axis, elution time on the x-axis, with the analyte and its impurities appearing as peaks. It is the raw evidence from which the purity percentage is derived, usually accompanied by an integration table listing each peak’s retention time, area, and area percent.

What you are looking for is internal consistency. One dominant peak with a handful of small, labeled neighbours and a flat baseline is consistent with a high-nineties purity figure. A trace showing several large unlabeled peaks underneath a headline “99.5%” is a document contradicting itself.

Red flag: the chromatogram is missing, is a low-resolution image too degraded to read, or is present but visibly inconsistent with the stated number. A purity percentage with no chromatogram is an assertion; a purity percentage above a legible, consistent chromatogram is evidence.

Retention time

Retention time is the interval between injection of the sample and the appearance of a given peak’s maximum at the detector, reported in minutes. It is a property of the analyte and the method: the same peptide will elute at a different time on a different column, gradient, flow rate, or mobile phase. IUPAC draws its retention definitions up in terms of volume, noting that where flow and recorder speeds are constant, volumes are directly proportional to times [9].

Its practical use on a COA is comparative. Within one report, the main peak’s retention time anchors the integration table so you can see which peak is the analyte. Across two reports from the same lab using the same method, a consistent retention time for the same compound is a mild consistency signal.

Red flag: retention times quoted with no method conditions - no column, no gradient, no flow rate, no detection wavelength. Without those, the retention time is an uncheckable number, and any cross-report comparison you attempt with it is meaningless.

Net peptide content (NPC)

Net peptide content is the mass of actual peptide in the vial, as distinct from the gross mass of lyophilized powder you paid for. Lyophilized peptide is not pure peptide by weight: it also contains counterions bound at each protonatable site, residual water, and any salts carried through purification.

The theoretical NPC is straightforward arithmetic. Divide the peptide’s molecular weight by that molecular weight plus the counterion mass multiplied by the number of sites available to bind it:

NPC ≈ MW_peptide ÷ (MW_peptide + n × MW_counterion)

A worked example, using trifluoroacetate at ~114 Da: a 1,000 Da peptide with a free N-terminus and one lysine has two binding sites, giving 1000 ÷ (1000 + 2 × 114) = 1000 ÷ 1228 ≈ 81% net peptide content. The other ~19% of the powder mass is counterion.

The measured NPC is a different and better figure, obtained by amino-acid analysis or by a mass-balance approach that quantifies every non-peptide component and subtracts it. Mass-balance analysis for peptides is an established discipline precisely because the theoretical calculation assumes every site is occupied, which is rarely exactly true [4].

This is also the number that determines your real cost, which is why the cost-per-mg calculator works from net content rather than label weight, and why the reconstitution calculator takes net content as its input.

Red flag: NPC absent entirely. A “99% pure” vial with unstated content can hold less peptide than a “98% pure” vial that reports its milligrams honestly. Purity and content answer different questions.

TFA vs acetate salt form

Solid-phase peptide synthesis relies on trifluoroacetic acid as both the cleavage reagent and the ion-pairing agent in reversed-phase purification, so peptides are obtained as TFA salts by default [5][6]. Converting to another counterion - most commonly acetate, via repeated dissolution in dilute acetic acid followed by lyophilization, or by ion exchange - is a deliberate additional manufacturing step [5][6].

The consequence for a buyer is purely mass arithmetic. Trifluoroacetate contributes roughly 113-114 Da per bound site (113.02 Da for the anion, 114.02 Da for the free acid, and sources vary on which convention they cite); acetate contributes roughly 59-60 Da (59.04 Da for the anion, 60.05 Da for acetic acid) [18]. Run those through the NPC formula and the same peptide as an acetate salt carries more actual peptide per milligram of powder than as a TFA salt.

How much of the powder is counterion depends on both the peptide’s size and its number of basic residues, so it is worth computing rather than assuming. For mid-sized peptides with two to four binding sites, TFA typically works out to something on the order of 10-25% of the powder’s mass - but a small peptide with several basic residues goes higher, and a 1,000 Da peptide with four sites computes to about 31%.

A separate and honest caveat: residual TFA is measured, not assumed. Published work quantifies it by ¹⁹F-NMR, FT-IR, or HPLC with evaporative light-scattering detection, and the measured value often differs from the theoretical maximum because not every basic site is actually occupied [5][6].

Red flag: the salt form is never declared anywhere on the COA or the product page. Without it, net content cannot be estimated even roughly, and two vendors’ “5 mg” vials are not comparable.

Lot / batch number

A batch is “a specific quantity of a drug or other material that is intended to have uniform character and quality, within specified limits, and is produced according to a single manufacturing order during the same cycle of manufacture.” A lot number, control number, or batch number is “any distinctive combination of letters, numbers, or symbols… from which the complete history of the manufacture, processing, packing, holding, and distribution of a batch or lot… can be determined.” Those are the formal US regulatory definitions at 21 CFR 210.3 [10] - and while research-use-only material is not manufactured under those rules, the concept is identical and the vocabulary is borrowed from them.

This is the load-bearing field on the entire document. A COA certifies one submitted sample from one batch - not the product line, not your specific vial, and not next month’s production run. The only thing connecting an authentic lab report to the vial in your hand is the lot number appearing identically on both.

Red flag: the lot field is blank on the COA, or it is populated but does not match the number printed on the vial you received. A genuine report for a different lot is a recycled COA, and recycling real reports across new stock is among the most common forms of COA deception precisely because the document itself survives scrutiny.

Accession number (or report / order number)

An accession number is the identifier a laboratory assigns to a sample when it is logged into the lab’s system, and it is the key you use to re-open that record on the lab’s own public database. Different labs name the field differently - accession number, report number, order number, search code, verification code - but the function is identical. Some labs also prefix the accession with a short company code to build the string you actually type into their lookup form, so read the field label on the report rather than guessing.

Its entire value is resolvability. An accession that returns a live record matching the compound, batch, purity, and methods on the PDF converts a document into a checkable fact. An accession that returns nothing tells you the document is unverifiable, and an unverifiable COA is worth what no COA is worth. Type the lab’s domain into your browser yourself rather than following a link the vendor supplied; the full procedure is in the COA lookup walkthrough.

Red flag: no code at all, a code that will not resolve, or a “verification portal” hosted on a domain the vendor controls rather than the laboratory’s. Lookalike verification domains exist, and being routed to one is itself the finding.

Test date and sample-received date

Reports carry at least one and usually two dates: when the lab received the submitted sample, and when the analysis was performed or the report issued. Together they place the report in time relative to the stock being sold.

Purity is batch-specific and time-bounded. A report is evidence about the batch it was drawn from, at the time it was drawn. It is not a permanent certificate covering everything a vendor ships thereafter.

Red flag: a COA years older than the stock on sale, or one report whose dates never change while the vendor cycles through visibly new batches. Reputable operations re-test new lots, and the accession you look up should correspond to current stock.

Accreditation (ISO/IEC 17025 and others)

Accreditation is formal third-party recognition that a laboratory is competent to perform specific tests. The governing standard for testing laboratories is ISO/IEC 17025:2017, which sets general requirements for the competence, impartiality, and consistent operation of testing and calibration laboratories, and which accreditation bodies use as their assessment criteria [11].

Two things are worth separating carefully. Accreditation is scoped: a lab is accredited for named test methods listed on its scope document, not accredited in general, so “ISO 17025 accredited” with no scope is a half-statement. And accreditation is independently checkable: US accreditation bodies publish searchable directories, including A2LA at customer.a2la.org and ANAB at search.anab.org. If a lab’s accreditation matters to your decision, look it up in the accreditation body’s directory rather than accepting a badge image.

Red flag: an accreditation logo displayed on the vendor’s website rather than the laboratory’s, with no certificate number, no scope document, and no directory entry. Note also that accreditation and report verifiability are independent properties - a lab can publish fully resolvable records without being accredited, and an accredited lab’s report is still useless to you if you cannot re-open it.

LOD, LOQ, and the impurity reporting threshold

The limit of detection (LOD) is the smallest amount of an analyte the method can reliably detect; the limit of quantitation (LOQ) is the smallest amount it can measure with acceptable precision and accuracy. Both are formal validation characteristics under ICH Q2(R2) [12].

The numbers people have in mind when they say impurities are reported “down to about a tenth of a percent” come from ICH Q3A(R2). Its Attachment 1 sets, for a new drug substance with a maximum daily dose of 2 g/day or less, a reporting threshold of 0.05%, an identification threshold of 0.10% (or 1.0 mg per day intake, whichever is lower), and a qualification threshold of 0.15% (or 1.0 mg per day intake, whichever is lower) [15]. Those thresholds govern pharmaceutical drug substances rather than research-use-only material, but they are the origin of the expectation, and they are the reason a credible report quantifies small related substances instead of rounding them away.

The consequence: “no impurities detected” is not a statement about the sample unless the report also tells you the threshold below which it stopped looking. Every purity figure has an implicit floor.

Red flag: absolute claims - “no impurities”, “undetectable” - with no stated LOD, LOQ, or reporting threshold. And the broader “too perfect” pattern: a flat 100.0% purity is not a normal analytical output for a synthetic peptide, and a vendor whose every SKU and every batch carries the identical percentage is showing you a template rather than a measurement. Genuine per-sample testing produces variation between lots.

Specific tests: water content, residual solvents, endotoxin

Beyond identity and purity, fuller reports may include water content (typically Karl Fischer titration), residual solvents from synthesis and purification, counterion content, and bacterial endotoxin. USP General Chapter <1503>, Quality Attributes of Synthetic Peptide Drug Substances (official 1 August 2021), organizes these categories for synthetic peptides, and the EMA guideline on the development and manufacture of synthetic peptides covers analogous ground in Europe [13][14].

Most research-peptide COAs in this market do not include the full panel, and that is an honest limitation rather than automatic evidence of wrongdoing - a purity-plus-identity report is the realistic baseline here. What matters is that a partial panel is described accurately rather than dressed up.

Red flag: the inverse - a report claiming a complete pharmaceutical-grade panel with every parameter passing and no actual measured values, methods, or specification limits printed beside them. A flawless-everything report with no numbers is a design exercise, not an analysis.

---

Part 2: the “is this COA legit?” checklist

Run these seven questions against the report in front of you. Every one is answerable yes or no in under two minutes, and none of them requires you to trust the vendor.

#	Question	Yes means	No means
1	Is an outside laboratory named, with its own identity on the report?	An independent party is on the hook for the result	“Third-party tested” with no lab named is a self-issued claim
2	Is there an accession, report, or order number printed on it?	There is something to look up	There is nothing to check; the PDF is the entire claim
3	Does that number resolve on the lab’s own domain, typed in by you?	The report genuinely exists in the lab’s records	Unverifiable, however official the letterhead looks
4	Does the lot on the COA match the lot printed on your vial?	The report is about your stock	A real report about someone else’s batch
5	Are both HPLC purity and mass-spec identity present?	Both questions - how much, and what is it - are answered	Half a report
6	Is a legible chromatogram included and consistent with the stated percentage?	The number has visible evidence behind it	The number is an assertion
7	Was all of the above visible before you paid?	You could verify at decision time	“COA available on request” is not verification

How to score it, honestly. Questions 1, 3, and 4 are structural: fail any one of them and the report is not evidence, no matter how good the rest looks. Questions 5, 6, and 7 are quality gradations - a report that passes 1, 3, and 4 but omits the chromatogram is weaker than one that includes it, not worthless. Question 2 is simply the precondition for question 3.

A single failure on 1, 3, or 4 is a stop. Two or more failures anywhere is a pattern, and patterns are what the vendor red-flags checklist is built around.

---

How to use this glossary and checklist

Use it in the order the two parts are printed. Open the COA, read it against Part 1 so you know what each field actually claims, then run Part 2 to decide whether those claims are backed by anything. That order matters: the checklist is only meaningful once you can tell a purity figure from a net content figure, and the glossary is only useful if you then go and check the record.

Three caveats belong with any use of this page.

A verified COA is not a per-vial guarantee. Third-party labs test a submitted sample drawn from a lot, not every unit produced. A verified, lot-matched report proves that lot was genuinely tested and that the report is authentic. That is the strongest signal available in this market, and it is still not a guarantee about the individual vial in your hand. Anyone who tells you otherwise is overselling.

The checklist tests the document, not the material. Passing all seven questions confirms that an independent laboratory analyzed a sample from your batch and said what the vendor claims it said. It says nothing about handling after testing, storage conditions, or what happened to the material between the lab bench and your door.

Definitions here are general; individual labs vary. Field names, layout, which tests are included, and how thresholds are reported all differ between laboratories. The concepts are stable; the formatting is not. When a specific report uses a term this glossary does not cover, that is a question for the issuing lab, not a red flag by itself.

---

Sourcing and accuracy

Every definition and number on this page traces to a source, and where sources disagree the page says so rather than picking a figure and pretending to precision.

• Purity as area percent, and the 214-220 nm detection window. Standard reversed-phase HPLC practice for peptides [3], with impurities expressed against total detected area in peptide reference-standard work [1]. The peptide-bond molar extinction coefficient at 214 nm (923 M⁻¹cm⁻¹) is a measured value from Kuipers and Gruppen [7]. The practical consequence - that non-absorbing species are not counted in area percent - follows directly from how the calculation is defined; it is a logical consequence of the method, not a separately measured statistic.
• Mass-spec identity, monoisotopic vs average mass. Characterization practice from Chrone et al. [2]; standardized terminology from the IUPAC mass-spectrometry recommendations [8]. The ~0.06% gap between monoisotopic and average mass is computed from standard atomic weights and isotopic abundances, not a published constant - it tracks elemental composition (mostly carbon count), so it is an approximation to sanity-check with, not a value to compare against tightly. The angiotensin II figures are from PubChem [18].
• Counterion masses. Trifluoroacetate anion 113.02 Da; trifluoroacetic acid 114.02 Da; acetate anion 59.04 Da; acetic acid 60.05 Da, all per PubChem [18]. Sources genuinely differ on which to use in the net-content formula: the widely circulated theoretical calculation uses 114 for TFA and 59 for acetate, mixing the free-acid and anion conventions. The resulting difference in computed NPC is under one percentage point for typical peptides, but this page reports both rather than inventing a single correct figure.
• The 10-25% TFA-by-mass range. This is computed from the theoretical formula, not a measured survey statistic, and it is a typical case rather than a bound - the same arithmetic gives about 31% for a 1,000 Da peptide with four basic sites. Actual measured TFA content is frequently lower because not every protonatable site is occupied, and it must be determined analytically - by ¹⁹F-NMR, FT-IR, or HPLC-ELSD - rather than assumed [5][6].
• Net peptide content. Theoretical formula as above; measured NPC via amino-acid analysis or mass-balance assessment [4]. The theoretical and measured values are different quantities, and a good COA distinguishes them.
• Impurity thresholds. The 0.05% reporting / 0.10% identification / 0.15% qualification figures are quoted from Attachment 1 of ICH Q3A(R2), for a maximum daily dose of 2 g/day or less [15]. That guideline, along with ICH Q2(R2) for method validation, USP <1503> for synthetic peptide quality attributes, and the EMA synthetic peptides guideline, applies to pharmaceutical substances [12][13][14][15]. None of them govern research-use-only material sold outside a pharmaceutical supply chain, and this page does not claim they do - they are cited as the origin of an expectation, not as a rule binding any vendor here.
• Lot and batch definitions. Quoted from 21 CFR 210.3 [10], which formally applies to drug CGMP rather than RUO material. They are used here because the vocabulary on COAs is borrowed from them, not to imply research peptides are manufactured under those regulations.
• Accreditation. ISO/IEC 17025:2017 scope and purpose per ISO [11]. The A2LA and ANAB URLs are those bodies’ own public search pages [16][17]. This page asserts no accreditation status for any specific laboratory - if that matters to you, look the lab up yourself.
• The “realistic purity” heuristic. The observation that genuine reports show digits after the decimal and vary between lots is a pattern-recognition heuristic derived from how the measurement works, not a published distribution. There is no peer-reviewed survey of research-peptide COA purity values to cite, and this page will not invent one. Treat it as a prompt to look harder, not as a numerical threshold.

---

Why this matters for vetting a vendor

The reason a glossary belongs in a vendor-vetting cluster rather than a chemistry one is that COA vocabulary is the primary raw material of COA deception. Fabricating a plausible certificate requires no chemistry at all - it requires knowing which words appear on real ones. Purity percentages, method names, retention times, and lab letterheads are all free to type.

What is not free to fake is a record on a laboratory’s own infrastructure. That asymmetry is the entire basis of a defensible vendor ranking: rank on what can be independently confirmed, and discount everything else. Concretely, a vendor earns credit for naming a specific outside lab, publishing an accession that resolves on that lab’s domain, printing lot numbers that match its vials, showing both HPLC and MS, and making all of it visible before checkout. It earns no credit for a polished website, confident adjectives, “lab-tested” as a phrase, or a COA it will send you after you pay. The longer-form version of this reasoning is in the US vendor vetting guide.

The honest corollary cuts both ways, and it applies to this site as much as to anyone else: a vendor’s verified report on one product is evidence about that product’s batch and nothing else. Coverage on one SKU never transfers to another.

---

How Pepora fits

Pepora (peporalabs.com) is the store this site is affiliated with, and the useful thing to do here is run the Part 2 checklist against it plainly, including where it comes up short.

Pepora publishes Freedom Diagnostics third-party COAs for four SKUs. Freedom Diagnostics is a US laboratory based in Franklin, Tennessee, whose public COA database dates to 2023, and which states that every report it issues pairs HPLC purity with LC-MS identity confirmation and that its lookup is searchable by accession number or company name - so both the purity and identity halves of a report are covered, and both are re-openable by you at FreedomDiagnosticsTesting.com.

Product	Stated purity	Freedom lookup code
GHK-Cu	99.98%	Pepo2603130126
Tesamorelin	99.348%	Pepo2603130125
TB-500 / Thymosin Beta-4	99.699%	Pepo2603130123
GLP-3 RT	99.67%	Pepo2603130122

A note on that last column, because the label matters when you go to type it in. Freedom’s lookup form takes a “search code” built as the first four characters of the company name followed by the accession number - so Pepo identifies Pepora and the ten-digit remainder is the accession itself. Enter the full string as printed above.

Two observations, one favourable and one limiting.

The favourable one is checkable against this page’s own glossary: those four figures are all different from each other, and all carry digits after the decimal. That is what independently measured per-sample results look like, as opposed to one flattering number template-pasted across a catalog. Note the qualifier - it is consistent with genuine per-sample testing; the thing that actually confirms it is you resolving the codes yourself, which is why they are printed above rather than merely described.

The limiting one, stated plainly: only those four SKUs carry Freedom Diagnostics COAs. Pepora’s catalog is wider - BPC-157, Epitalon, Thymosin Alpha-1, ARA-290, and the KLOW, Glow, and Wolverine blends - and for those products there is no Freedom accession to look up. Do not let a strong GHK-Cu report stand in for verification of BPC-157. Under this page’s own checklist, a product with no verifiable third-party report fails question 3, and that verdict applies to Pepora’s untested SKUs exactly as it would to any other vendor’s. Orders ship from the US. Research use only.

---

The disclosed pick

---

FAQ

What does HPLC purity actually measure on a peptide COA? It measures area percent, not mass percent. The chromatograph separates the sample, a UV detector records the signal, and purity is the main peak’s area divided by the total area of all detected peaks. Because peptides are detected through the amide bond chromophore near 214-220 nm, anything that does not absorb there - water, inorganic salts, residual counterions - is invisible to the method and is simply not counted. That is why a 99% HPLC purity figure and net peptide content are two different numbers, and why a COA that reports only the first is incomplete.

What is net peptide content and why is it lower than the vial’s label weight? Net peptide content (NPC) is the actual mass of peptide in the vial, as opposed to the gross mass of lyophilized powder. The powder also contains bound counterions from purification, residual water, and any salts, all of which add weight. Theoretical NPC is peptide molecular weight divided by peptide MW plus the counterion mass at each protonatable site, so a 1,000 Da peptide with two basic sites as a TFA salt computes to roughly 81% net content. Measured NPC uses amino-acid analysis or a mass-balance approach rather than the theoretical formula.

What is the difference between TFA salt and acetate salt on a COA? Trifluoroacetic acid is used as the cleavage and ion-pairing reagent in solid-phase peptide synthesis, so peptides come off the purification step as TFA salts by default. Trifluoroacetate contributes about 113-114 Da per bound site; acetate contributes about 59-60 Da. An acetate-salt peptide therefore carries more actual peptide per milligram of powder than the same peptide as a TFA salt. Salt exchange is a deliberate extra manufacturing step, and a COA that never states the salt form leaves the net content ambiguous.

Is a peptide COA without a chromatogram trustworthy? Treat it as an assertion rather than evidence. The purity percentage is a number derived from the chromatogram; without the trace you cannot see whether one dominant peak really sits above small labeled impurities, whether the baseline is clean, or whether large unlabeled peaks contradict the stated figure. A printed number is trivially editable, whereas a chromatogram that disagrees with its own headline percentage is self-refuting. A report that omits the trace entirely is not automatically fake, but it gives you nothing to check.

What is an accession number on a peptide COA? It is the identifier the testing laboratory assigns to a submitted sample when it enters the lab’s system, and it is the key that lets you re-open that record on the lab’s own public database. It serves the same function as a report or order number on other labs’ certificates. Its value is entirely in resolvability: an accession that returns a live record matching the PDF converts the document from a claim into a checkable fact, and one that returns nothing tells you the PDF is unverifiable regardless of how official the letterhead looks.

Is a 100% purity result on a peptide COA a good sign? No, it is a reason to look harder. Chromatographic purity is bounded by what the method can detect, and the pharmaceutical reference framework - ICH Q3A(R2) - sets a 0.05% reporting threshold and a 0.10% identification threshold for impurities in a drug substance dosed at 2 g/day or less. Against that backdrop a real synthetic peptide report generally lands in the high nineties with digits after the decimal rather than at a flat 100%. Equally suspect is a vendor whose every product and every batch carries the identical percentage, since genuinely independent per-sample testing produces variation between lots.

---

References

1. McCarthy D, Han Y, Carrick K, Schmidt D, Workman W, Matejtschuk P, Duru C, Atouf F. Reference Standards to Support Quality of Synthetic Peptide Therapeutics. Pharm Res. 2023;40(6):1317-1328. PMID 36949371. https://pubmed.ncbi.nlm.nih.gov/36949371/
2. Chrone VG, Lorentzen A, Højrup P. Characterization of Synthetic Peptides by Mass Spectrometry. Methods Mol Biol. 2024;2821:83-89. PMID 38997482. https://pubmed.ncbi.nlm.nih.gov/38997482/
3. Mant CT, Chen Y, Yan Z, Popa TV, Kovacs JM, Mills JB, Tripet BP, Hodges RS. HPLC analysis and purification of peptides. Methods Mol Biol. 2007;386:3-55. PMID 18604941. https://pubmed.ncbi.nlm.nih.gov/18604941/
4. Hetrick EM, Pack BW, Wolfe CN, Zhao M. Mass balance analysis for therapeutic peptides: case studies, applications, and perspectives. J Pharm Biomed Anal. 2025;252:116501. PMID 39442464. https://pubmed.ncbi.nlm.nih.gov/39442464/
5. Erckes V, Streuli A, Chamera Rendueles L, Krämer SD, Steuer C. Towards a Consensus for the Analysis and Exchange of TFA as a Counterion in Synthetic Peptides and Its Influence on Membrane Permeation. Pharmaceuticals. 2025;18(8):1163. PMID 40872554. doi:10.3390/ph18081163. https://pmc.ncbi.nlm.nih.gov/articles/PMC12389442/
6. Roux S, Zékri E, Rousseau B, Paternostre M, Cintrat JC, Fay N. Elimination and exchange of trifluoroacetate counter-ion from cationic peptides: a critical evaluation of different approaches. J Pept Sci. 2008;14(3):354-359. PMID 18035848. doi:10.1002/psc.951. https://pubmed.ncbi.nlm.nih.gov/18035848/
7. Kuipers BJH, Gruppen H. Prediction of molar extinction coefficients of proteins and peptides using UV absorption of the constituent amino acids at 214 nm to enable quantitative reverse phase high-performance liquid chromatography-mass spectrometry analysis. J Agric Food Chem. 2007;55(14):5445-5451. PMID 17539659. https://pubmed.ncbi.nlm.nih.gov/17539659/
8. Murray KK, Boyd RK, Eberlin MN, Langley GJ, Li L, Naito Y. Definitions of terms relating to mass spectrometry (IUPAC Recommendations 2013). Pure Appl Chem. 2013;85(7):1515-1609. doi:10.1351/PAC-REC-06-04-06. https://doi.org/10.1351/PAC-REC-06-04-06
9. IUPAC. Compendium of Chemical Terminology (the “Gold Book”) - retention volumes in chromatography (R05366). doi:10.1351/goldbook.R05366. https://goldbook.iupac.org/terms/view/R05366
10. US FDA. 21 CFR 210.3 - Definitions (batch; lot; lot number, control number, or batch number). https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-210/section-210.3
11. ISO/IEC 17025:2017. General requirements for the competence of testing and calibration laboratories. https://www.iso.org/standard/66912.html
12. ICH. Q2(R2): Validation of Analytical Procedures. FDA guidance copy: https://www.fda.gov/media/161201/download
13. USP. General Chapter <1503>: Quality Attributes of Synthetic Peptide Drug Substances (official 1 Aug 2021). https://doi.usp.org/USPNF/USPNF_M12935_02_01.html
14. European Medicines Agency. Guideline on the Development and Manufacture of Synthetic Peptides. https://www.ema.europa.eu/en/development-manufacture-synthetic-peptides-scientific-guideline
15. ICH. Q3A(R2): Impurities in New Drug Substances (Step 4, 25 October 2006); thresholds at Attachment 1. https://database.ich.org/sites/default/files/Q3A%28R2%29%20Guideline.pdf
16. A2LA accredited organization directory. https://customer.a2la.org/index.cfm?event=directory.index
17. ANAB accredited organization directory. https://search.anab.org/
18. PubChem, National Library of Medicine. Compound records: trifluoroacetic acid (CID 6422), trifluoroacetate (CID 84468), acetic acid (CID 176), acetate (CID 175), angiotensin II (CID 172198). https://pubchem.ncbi.nlm.nih.gov/

---

coaindex is a Pepora affiliate (peporalabs.com) and earns a commission on purchases made with the code above. This is affiliate education, not journalism, and it ranks vendors on checkable, independently verifiable third-party-COA criteria. Research use only. Not for human or veterinary use, and nothing here is medical advice.